Andra Ap Fonden Gilead Sciences, Inc. Transaction History

Andra Ap Fonden

$7.41 Billion
Q3 2025

A detailed history of Andra Ap Fonden transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Andra Ap Fonden holds 597,500 shares of GILD stock, worth $74.1 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares

597,500

Previous 577,800 3.41%

Holding current value

$74.1 Million

Previous $64.1 Million 3.53%

% of portfolio

0.89%

Previous 0.93%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$108.22 - $120.47 $2.13 Million - $2.37 Million	19,700 Added 3.41%	597,500 $66.3 Million
Q2 2025 Aug 06, 2025	BUY	$96.91 - $113.0 $32.7 Million - $38.1 Million	337,100 Added 140.05%	577,800 $64.1 Million
Q1 2025 May 13, 2025	SELL	$89.14 - $117.41 $7.23 Million - $9.52 Million	-81,100 Reduced 25.2%	240,700 $27 Million
Q4 2024 Feb 07, 2025	SELL	$83.95 - $97.9 $6.44 Million - $7.51 Million	-76,700 Reduced 19.25%	321,800 $29.7 Million
Q3 2024 Nov 12, 2024	SELL	$66.59 - $83.99 $1.21 Million - $1.53 Million	-18,200 Reduced 4.37%	398,500 $33.4 Million

Q2 2024 Aug 07, 2024	SELL	$63.15 - $72.88 $9.86 Million - $11.4 Million	-156,200 Reduced 27.26%	416,700 $28.6 Million
Q1 2024 May 13, 2024	BUY	$71.58 - $87.29 $41 Million - $50 Million	572,900 New	572,900 $42 Million
Q2 2023 Aug 09, 2023	SELL	$76.01 - $86.7 $2.68 Million - $3.06 Million	-35,300 Reduced 13.14%	233,400 $18 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $7.24 Million - $8.24 Million	93,600 Added 53.46%	268,700 $22.3 Million
Q4 2022 Feb 13, 2023	BUY	$62.32 - $89.47 $573,344 - $823,124	9,200 Added 5.55%	175,100 $15 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $309,608 - $353,652	5,200 Added 3.24%	165,900 $10.2 Million
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $352,092 - $396,561	6,100 Added 3.95%	160,700 $9.93 Million
Q4 2021 Feb 15, 2022	SELL	$64.88 - $73.64 $1.56 Million - $1.77 Million	-24,000 Reduced 13.44%	154,600 $11.2 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $676,900 - $730,300	10,000 Added 5.93%	178,600 $12.5 Million
Q2 2021 Aug 16, 2021	BUY	$63.47 - $69.35 $4.18 Million - $4.56 Million	65,800 Added 64.01%	168,600 $11.6 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $1.85 Million - $2.11 Million	-30,800 Reduced 23.05%	102,800 $6.64 Million
Q4 2020 Feb 12, 2021	BUY	$56.65 - $64.55 $1.08 Million - $1.23 Million	19,100 Added 16.68%	133,600 $7.78 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $360,180 - $452,864	-5,800 Reduced 4.82%	114,500 $7.24 Million
Q2 2020 Aug 06, 2020	SELL	$72.34 - $84.0 $549,784 - $638,400	-7,600 Reduced 5.94%	120,300 $9.26 Million
Q1 2020 May 13, 2020	BUY	$62.63 - $80.22 $663,878 - $850,332	10,600 Added 9.04%	127,900 $9.56 Million
Q4 2019 Feb 10, 2020	SELL	$61.62 - $67.78 $73,944 - $81,336	-1,200 Reduced 1.01%	117,300 $7.62 Million
Q3 2019 Nov 19, 2019	SELL	$62.51 - $69.0 $1 Million - $1.1 Million	-16,000 Reduced 11.9%	118,500 $7.51 Million
Q2 2019 Aug 15, 2019	SELL	$61.87 - $69.38 $637,261 - $714,614	-10,300 Reduced 7.11%	134,500 $9.09 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $2.64 Million - $2.96 Million	-42,200 Reduced 22.57%	144,800 $9.41 Million
Q3 2018 Oct 16, 2018	BUY	$71.28 - $78.92 $577,368 - $639,252	8,100 Added 4.53%	187,000 $14.4 Million
Q2 2018 Aug 17, 2018	BUY	$64.88 - $75.68 $1.14 Million - $1.33 Million	17,600 Added 10.91%	178,900 $12.7 Million
Q1 2018 Apr 10, 2018	BUY	$72.84 - $88.8 $4.34 Million - $5.29 Million	59,600 Added 58.6%	161,300 $12.2 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $1.66 Million - $1.95 Million	23,300 Added 29.72%	101,700 $7.29 Million
Q3 2017 Oct 31, 2017	BUY	$72.11 - $85.47 $5.65 Million - $6.7 Million	78,400	78,400 $6.35 Million

Others Institutions Holding GILD

# of Institutions

2,396

Shares Held

1.01B

Call Options Held

8.58M

Put Options Held

7.35M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $156B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Andra Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Andra Ap Fonden with notifications on news.

Account